C86.60 Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
Billable ICD-10-CM code, FY2026. Acts as a Complication or Comorbidity (CC) as a secondary diagnosis.
Applicable to
Lymphomatoid papulosis NOS
Lymphomatoid papulosis not having achieved remission
Lymphomatoid papulosis with failed remission
Primary cutaneous anaplastic large cell lymphoma NOS
Primary cutaneous anaplastic large cell lymphoma not having achieved remission
Primary cutaneous anaplastic large cell lymphoma with failed remission
Primary cutaneous CD30-positive large T-cell lymphoma NOS
Primary cutaneous CD30-positive large T-cell lymphoma not having achieved remission
Primary cutaneous CD30-positive large T-cell lymphoma with failed remission
Primary cutaneous CD30-positive T-cell proliferations NOS
Primary cutaneous CD30-positive T-cell proliferations with failed remission
Applies from C86 Other specified types of T/NK-cell lymphoma
Excludes1 (never code together)
anaplastic large cell lymphoma, ALK negative (C84.7-)
anaplastic large cell lymphoma, ALK positive (C84.6-)
mature T/NK-cell lymphomas (C84.-)
other specified types of non-Hodgkin lymphoma (C85.8-)
Applies from C86.6 Primary cutaneous CD30-positive T-cell proliferations
Applicable to
Lymphomatoid papulosis
Primary cutaneous anaplastic large cell lymphoma
Primary cutaneous CD30-positive large T-cell lymphoma
Risk adjustment (HCC)
CMS-HCC V28: HCC 20 — Lung and Other Severe Cancers
CMS-HCC V22: HCC 10 — Lymphoma and Other Cancers
RxHCC V08: HCC 21 — Lymphomas and Other Hematologic Cancers
ESRD V24: HCC 10
MS-DRG index
Defines the logic of DRG(s) 820-822 in MDC 17.
Code annotations containing back-references to C86.60
Back-references to C86.60
Type 1 Excludes: C84.Z Other mature T/NK-cell lymphomas ("primary cutaneous CD30-positive T-cell proliferations (C86.60)")
Back-references to C86.6
Type 1 Excludes: C84.7 Anaplastic large cell lymphoma, ALK-negative ("primary cutaneous CD30-positive T-cell proliferations (C86.6-)")
Back-references to C86
Type 1 Excludes: C76 Malignant neoplasm of other and ill-defined sites ("malignant neoplasm of lymphoid, hematopoietic and related tissue (C81-C96)")
Type 1 Excludes: C77 Secondary and unspecified malignant neoplasm of lymph nodes ("malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)")
Type 1 Excludes: C85 Other specified and unspecified types of non-Hodgkin lymphoma ("other specified types of T/NK-cell lymphoma (C86.-)")
Code First: Z15.0 Genetic susceptibility to malignant neoplasm (", if applicable, any current malignant neoplasm (C00-C75, C81-C96)")